Metal based neurodegenerative diseases - From molecular mechanisms to therapeutic strategies

被引:230
|
作者
Crichton, Robert R. [1 ]
Dexter, D. T. [2 ]
Ward, Roberta J. [1 ,2 ,3 ]
机构
[1] Catholic Univ Louvain, Unite Biochim, B-1348 Louvain, Belgium
[2] Imperial Coll, Dept Cellular & Mol Neurosci, London W6 8RF, England
[3] Univ Florence, Dipartimento Farmacol Preclin, I-50121 Florence, Italy
关键词
neurodegeneration; iron; copper; zinc; Parkinson's disease; Alzheimer's disease; therapeutics;
D O I
10.1016/j.ccr.2007.10.019
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The hypothesis is presented that changes in metal ion homeostatic control, particularly of redox-active metals such as iron and copper, in specific brain regions, leads to the generation of reactive oxygen species, which either directly damage key proteins, or lead to the formation of reactive aldehydes. These, in turn, generate protein carbonyls, leading to protein denaturation, aggregation, and a failure of the ubiquitin/proteasome system to eliminate these defective proteins. We present the evidence for metal based neurodegeneration in Parkinson's and Alzheimer's disease. Possible therapeutic strategies are presented which could remove such excesses of these specific metals and lead to the diminishment of the neurodegenerative processes. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:1189 / 1199
页数:11
相关论文
共 50 条
  • [21] The Implication of Reticulons (RTNs) in Neurodegenerative Diseases: From Molecular Mechanisms to Potential Diagnostic and Therapeutic Approaches
    Kulczynska-Przybik, Agnieszka
    Mroczko, Piotr
    Dulewicz, Maciej
    Mroczko, Barbara
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [22] Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies
    Pierre J. Marie
    [J]. Cellular and Molecular Life Sciences, 2015, 72 : 1347 - 1361
  • [23] Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies
    Marie, Pierre J.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (07) : 1347 - 1361
  • [24] New Therapeutic Strategies for Treatment of Neurodegenerative Diseases
    Kazantsev, Aleksey G.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (34) : 3917 - 3918
  • [25] Neurodegenerative Diseases: Molecular Mechanisms and Therapies
    Zhou, Zhi Dong
    Kihara, Alexandre Hiroaki
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [26] Nucleotides regulate the common molecular mechanisms that underlie neurodegenerative diseases; Therapeutic implications
    Sebastian-Serrano, Alvaro
    de Diego-Garcia, Laura
    di Lauro, Caterina
    Bianchi, Carolina
    Diaz-Hernandez, Miguel
    [J]. BRAIN RESEARCH BULLETIN, 2019, 151 : 84 - 91
  • [27] The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
    Rozpedek-Kaminska, Wioletta
    Siwecka, Natalia
    Wawrzynkiewicz, Adam
    Wojtczak, Radoslaw
    Pytel, Dariusz
    Diehl, J. Alan
    Majsterek, Ireneusz
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
  • [28] Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential
    Fan, Dahua
    Liu, Liping
    Wu, Zhengzhi
    Cao, Meiqun
    [J]. CURRENT NEUROPHARMACOLOGY, 2019, 17 (06) : 563 - 579
  • [29] Aggregopathy in neurodegenerative diseases:: Mechanisms and therapeutic implication
    Dohm, C. P.
    Kermer, P.
    Baehr, M.
    [J]. NEURODEGENERATIVE DISEASES, 2008, 5 (06) : 321 - 338
  • [30] Nanotechnology to the Rescue: Therapeutic Strategies Based on Brown Algae for Neurodegenerative Diseases
    Goncalves, Anabela
    Fernandes, Mario
    Lima, Margarida
    Gomes, Joao Pedro
    Silva, Filipa
    Castro, Sara
    Sampaio, Filipa
    Gomes, Andreia Castro
    [J]. APPLIED SCIENCES-BASEL, 2023, 13 (03):